New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2013
12:31 EDTRFMD, GS, CLMT, SONC, ZIOP, BRK.AOn The Fly: Midday Wrap
Stocks on Wall Street were higher right out of the gate and have not moved far from their opening levels near midday. Investors received a fair amount of domestic economic data, including better than expected reports on home prices and durable goods orders. The flip side, however, was some worse than expected consumer confidence and new home sales data. Despite the mixed data, the market seems intent on closing the quarter with its gains intact as the end of the month approaches... ECONOMIC EVENTS: In the U.S., overall orders for durable goods rose 5.7% in February, versus expectations for an increase of 3.9%. However, excluding transportation, orders slipped 0.5%, versus expectations for a 0.6% rise. The S&P/Case-Shiller 20-city home price index climbed 8.1% in the 12 months ending in January, after rising 6.8% a month earlier. New home sales dropped 4.6% to 411K in February, versus expectations for a decline to 414K. Consumer confidence fell 8.3 points to 59.7 in March, which was worse than the expected pull back to 69.0. The Richmond Fed manufacturing survey reading of 3 for March missed expectations for it to hold at 6... COMPANY NEWS: Goldman Sachs (GS) announced that it amended its warrant agreement with Berkshire Hathaway (BRK.A) to settle in terms of net shares in place of a cash settlement, quoting Berkshire's Chairman and CEO Warren Buffett as having said, "We intend to hold a significant investment in Goldman Sachs." Shares of Goldman, which rose early in the session, were down fractionally near noon... MAJOR MOVERS: Among the notable gainers were Sonic (SONC), which rose 8% following its earnings report, and RF Micro Devices (RFMD), which rallied nearly 6% after Oppenheimer upgraded the stock to an Outperform rating. Among the noteworthy losers was Ziopharm (ZIOP), which was downgraded by at least four analyst firms and plunged over 61% after terminating development of a cancer drug after a clinical study missed its goal. Also lower were shares of Calumet Specialty Products (CLMT), down 4% after an offering of 5.25M of its shares priced at $37.50... INDICES: Near midday, the Dow was up 74.84, or 0.52%, to 14,522.59; the Nasdaq was up 5.90, or 0.18%, to 3,241.20; and the S&P 500 was up 6.36, or 0.41%, to 1,558.05.
News For A;SONC;RFMD;ZIOP;CLMT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:42 EDTZIOPZiopharm in talks with large drug companies, says BMO Capital
Subscribe for More Information
07:35 EDTCLMTCalumet reports Q4 EPS excl items 86c, may not be comparable to 10c
Reports Q4 net income (95c). Reports Q4 revenue $1.34B, consensus $1.45B. Reports Q4 total sales volume of 122,945 bpd. Reports Q4 total facility production of 117,973 bpd.
07:33 EDTCLMTCalumet Specialty Products expects to purchase blending credits RINs
Subscribe for More Information
07:33 EDTCLMTCalumet Specialty Products sees FY15 CapEx $285M-$335M
Subscribe for More Information
February 26, 2015
17:25 EDTZIOPZiopharm reports Q4 EPS (9c) with items, consensus (14c)
Subscribe for More Information
06:09 EDTZIOPStocks with implied volatility movement; NWBO ZIOP
Subscribe for More Information
February 25, 2015
15:51 EDTZIOPZiopharm March volatility elevated, March calls active
Subscribe for More Information
10:01 EDTAOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:28 EDTAAgilent upgraded to Buy from Neutral at BTIG
Subscribe for More Information
07:18 EDTAG Corp to hold annual meeting
Subscribe for More Information
February 24, 2015
10:59 EDTZIOPZiopharm March volatility elevated
Subscribe for More Information
February 19, 2015
09:09 EDTALeerink's life science tools analyst holds an analyst/industry conference call
Subscribe for More Information
February 17, 2015
16:09 EDTAAgilent sees FY15 EPS $1.67- $1.73, consensus $1.73
Subscribe for More Information
16:08 EDTAAgilent sees Q2 EPS 37c-41c, consensus $39c
Subscribe for More Information
16:07 EDTAAgilent reports Q1 EPS 41c, consensus 41c
Subscribe for More Information
15:32 EDTANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Devon Energy (DVN), consensus $1.05... Vornado Realty (VNO), consensus $1.23... Analog Devices (ADI), consensus 61c... FirstEnergy (FE), consensus 75c... CF Industries (CF), consensus $5.08... Agilent Technologies (A), consensus 41c... Cimarex Energy (XEC), consensus 82c... Flowserve (FLS), consensus $1.13... Fossil (FOSL), consensus $3.07... Rackspace (RAX), consensus 19c... Norwegian Cruise Line (NCLH), consensus 37c... Jack in the Box (JACK), consensus 87c... Cloud Peak Energy (CLD), consensus 7c... La-Z-Boy (LZB), consensus 38c... KAR Auction Services (KAR), consensus 29c... Owens & Minor (OMI), consensus 50c... Valmont Industries (VMI), consensus $1.65... Realty Income (O), consensus 66c.
February 16, 2015
10:54 EDTADako and Ono Pharmaceutical announce collaboration
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Ono Pharmaceutical announced a new partnership to develop a potential diagnostic test specifically for use with Opdivo in the treatment of non-small cell lung cancer, NSCLC. This test is being investigated for its diagnostic utility to determine which patients are most likely to respond to Opdivo.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use